Review ArticleInternational Journal of Basic & Clinical Pharmacology

Publication:
Anti-nicotine vaccine: current status

Int J Basic Clin Pharmacol. 2015;4(6):1309-1313.DOI10.18203/2319-2003.ijbcp20151380

Thumbnail Image
View on the journal's website(opens in a new tab)

Abstract

Tobacco abuse has an enormous impact on health. Nicotine is the main substance responsible for dependence on tobacco-containing products. The vast majority of cigarette smokers who try to quit ultimately fail because of high relapse rates. Clearly, novel approaches are needed for the treatment and prevention of nicotine addiction. Having an efficient vaccine that would generate antibodies to sequester the drug and prevent its access to the brain could go a long way toward helping a motivated addict quit an addiction.

Keywords

Affiliations

  1. Department of Pharmacology, Teerthanker Mahaveer Medical College and Research Centre, Moradabad, Uttar Pradesh, India
  2. Department of Oral Medicine and Radiology, Teerthanker Mahaveer Dental College and Research Centre, Moradabad, Uttar Pradesh, India
  3. Department of Pulmonary Medicine, Darbhanga Medical College and Hospital, Darbhanga, Bihar, India

Full item record